Literature DB >> 19243854

Hepatocellular carcinoma in HIV-infected patients comes of age: The convergence of epidemiology and treatment effectiveness.

Mark Sulkowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19243854     DOI： 10.1016/j.jhep.2009.01.009

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  9 in total

1.  Malignancies in HIV/AIDS patients attending an outpatient clinic in Vitória, State of Espírito Santo, Brazil.

Authors:  Lauro Ferreira da Silva Pinto Neto; Maria da Conceição Milanez; Jonathan Eric Golub; Angelica Espinosa Barbosa Miranda
Journal:  Rev Soc Bras Med Trop       Date:  2012-12       Impact factor: 1.581

2.  Non-AIDS-Defining Malignancies in the HIV-Infected Population.

Authors:  Chia-Ching J Wang; Michael J Silverberg; Donald I Abrams
Journal:  Curr Infect Dis Rep       Date:  2014-06       Impact factor: 3.725

3.  The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States.

Authors:  Vikrant V Sahasrabuddhe; Meredith S Shiels; Katherine A McGlynn; Eric A Engels
Journal:  Cancer       Date:  2012-06-26       Impact factor: 6.860

4.  Sorafenib therapy for hepatocellular carcinoma in an HIV-HCV coinfected patient: a case report.

Authors:  Giorgio Perboni; Paolo Costa; Giovanni Carlo Fibbia; Barbara Morandini; Alfredo Scalzini; Alberto Tagliani; Rita Cengarle; Enrico Aitini
Journal:  Oncologist       Date:  2010-02-08

5.  Hepatocellular carcinoma in a teenager with perinatally acquired HIV Infection without hepatitis B or C coinfection: a case report.

Authors:  Maya Venkataramani; Nancy Hutton; Paul Colombani; Robert A Anders; Allison L Agwu
Journal:  AIDS Patient Care STDS       Date:  2010-10-23       Impact factor: 5.078

6.  Prevalence of Hepatocellular Carcinoma in HIV Patients Co-infected or Triple Infected With Hepatitis B and Hepatitis C in a Community Hospital in South Bronx.

Authors:  Shehriyar Mehershanhi; Asim Haider; Sameer Kandhi; Haozhe Sun; Harish Patel
Journal:  Cureus       Date:  2022-06-19

Review 7.  Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.

Authors:  Cristina Della Corte; Alessio Aghemo; Massimo Colombo
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

8.  Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study.

Authors:  Daria Gotti; Elena Raffetti; Laura Albini; Laura Sighinolfi; Franco Maggiolo; Elisa Di Filippo; Nicoletta Ladisa; Gioacchino Angarano; Giuseppe Lapadula; Angelo Pan; Anna Degli Esposti; Massimiliano Fabbiani; Emanuele Focà; Alfredo Scalzini; Francesco Donato; Eugenia Quiros-Roldan
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

9.  Treatment of Recurrent Hepatocellular Carcinoma with Sorafenib in a HIV/HCV Co-Infected patient in HAART: A Case Report.

Authors:  Pasquale De Nardo; Magdalena Viscione; Angela Corpolongo; Rita Bellagamba; Giovanni Vennarecci; Giuseppe Maria Ettorre; Elisa Gentilotti; Chiara Tommasi; Emanuele Nicastri
Journal:  Infect Agent Cancer       Date:  2012-06-28       Impact factor: 2.965
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.